High-level expression of receptor tyrosine kinase Ret and responsiveness to Ret-activating ligands in pheochromocytoma cell lines from neurofibromatosis knockout mice

James F. Powers*, Kimberley Schelling, Jaime M. Brachold, Panayiotis Tsokas, Hagit Schayek, Eitan Friedman, Arthur S. Tischler

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Pheochromocytoma cell lines derived from neurofibromatosis knockout mice express high levels of the receptor tyrosine kinase Ret, which is involved in the pathogenesis of human pheochromocytomas in hereditary multiple endocrine neoplasia syndrome type 2 (MEN2). Mouse pheochromocytoma (MPC) cells respond to the Ret-activating ligand GDNF by exhibiting Ret phosphorylation, neurite outgrowth, decreased proliferation, and altered expression of catecholamine biosynthetic enzymes. GDNF exerts similar effects on human pheochromocytoma cells in primary cultures. Ret is minimally expressed by normal mouse chromaffin cells, from which pheochromocytomas are derived. Its expression at high levels by MPC cells suggests possible relationships between two previously unrelated tumor syndromes, neurofibromatosis, and MEN2. The responsiveness of these cells to GDNF suggests that they may be a valuable new model for neurobiology.

Original languageEnglish
Pages (from-to)382-389
Number of pages8
JournalMolecular and Cellular Neuroscience
Volume20
Issue number3
DOIs
StatePublished - 2002
Externally publishedYes

Funding

FundersFunder number
U.S. NIHNS37685
National Cancer InstituteR01CA048017

    Fingerprint

    Dive into the research topics of 'High-level expression of receptor tyrosine kinase Ret and responsiveness to Ret-activating ligands in pheochromocytoma cell lines from neurofibromatosis knockout mice'. Together they form a unique fingerprint.

    Cite this